Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329 (28 August), doi:10.1136/bmj.329.7464.0-a
Long courses of corticosteroids may reduce mortality in patients who have severe sepsis and septic shock. Reviewing 16 trials on 2063 patients, Annane and colleagues (p 480) found that corticosteroid did not change mortality at 28 days or hospital mortality. However, those patients who had low dose hydrocortisone (
300 mg) for at least five days were more likely to survive, without increased risk of gastroduodenal bleeding, superinfection, or hyperglycaemia, than those receiving a short course of corticosteroids or placebo. This treatment may be more effective in patients with impaired production of corticosteroids, say the authors.
|
|
Credit: JOISIN/PHANIE/REX
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?